[go: up one dir, main page]

AU2003287388A1 - Inhibition of hiv-1 replication - Google Patents

Inhibition of hiv-1 replication

Info

Publication number
AU2003287388A1
AU2003287388A1 AU2003287388A AU2003287388A AU2003287388A1 AU 2003287388 A1 AU2003287388 A1 AU 2003287388A1 AU 2003287388 A AU2003287388 A AU 2003287388A AU 2003287388 A AU2003287388 A AU 2003287388A AU 2003287388 A1 AU2003287388 A1 AU 2003287388A1
Authority
AU
Australia
Prior art keywords
hiv
replication
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003287388A
Other versions
AU2003287388A8 (en
Inventor
Amartya Basu
Ralph A. Casale Iii
Neerja Kaushik
Rene L. Myers
Paul Palumbo
Virendra N. Pandey
Bechan Sharma
Tanaji T. Talele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers Health
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of AU2003287388A8 publication Critical patent/AU2003287388A8/en
Publication of AU2003287388A1 publication Critical patent/AU2003287388A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003287388A 2002-11-01 2003-10-31 Inhibition of hiv-1 replication Abandoned AU2003287388A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42301502P 2002-11-01 2002-11-01
US60/423,015 2002-11-01
PCT/US2003/034708 WO2004041194A2 (en) 2002-11-01 2003-10-31 Inhibition of hiv-1 replication

Publications (2)

Publication Number Publication Date
AU2003287388A8 AU2003287388A8 (en) 2004-06-07
AU2003287388A1 true AU2003287388A1 (en) 2004-06-07

Family

ID=32312588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003287388A Abandoned AU2003287388A1 (en) 2002-11-01 2003-10-31 Inhibition of hiv-1 replication

Country Status (2)

Country Link
AU (1) AU2003287388A1 (en)
WO (1) WO2004041194A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1657306B1 (en) * 2004-11-16 2011-04-13 QIAGEN GmbH Gene silencing using sense DNA and antisense RNA hybrid constructs coupled to peptides facilitating the uptake into cells
US9617606B2 (en) * 2012-01-25 2017-04-11 Japan Science And Technology Agency Oligonucleotide for HIV detection, HIV detection kit, and HIV detection method
CN110023321A (en) 2016-08-17 2019-07-16 索尔斯蒂斯生物有限公司 Polynucleotide constructs
WO2019006455A1 (en) 2017-06-30 2019-01-03 Solstice Biologics, Ltd. Chiral phosphoramidite auxiliaries and methods of their use

Also Published As

Publication number Publication date
WO2004041194A2 (en) 2004-05-21
WO2004041194A3 (en) 2005-04-21
AU2003287388A8 (en) 2004-06-07

Similar Documents

Publication Publication Date Title
AU2003261434A1 (en) Iminothiazolidinones as inhibitors of hcv replication
AU2003248872A1 (en) Hiv integrase inhibitors
AU2003236991A1 (en) Representations of processes
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003222197A1 (en) Inhibition of rna function
AU2003260778A1 (en) Treatment of pipes
AU2003290939A1 (en) Replication of biological tiussue
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003249930A1 (en) Proteaseome inhibitors for the treatment of herpesviridae infected individuals
AU2003287388A1 (en) Inhibition of hiv-1 replication
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2003299137A1 (en) Inhibition of metallo-beta-lactamase
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2002305868A1 (en) Inhibitors of reggamma
AU2003279180A1 (en) Potentiating the antipyretic action of nonopioid analgesic
AU2003237157A1 (en) Preparation of phosphatase inhibitors
AU2003208809A1 (en) Treatment of neuroblastoma
AU2002321556A1 (en) Inhibition of replication factor c
AU2003902961A0 (en) Inhibition of viral replication using viperin
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003213601A1 (en) Case hardening of titanium
AU2003216907A1 (en) Anti-inflammatory morpholin-acetamide derivatives
AU2003261598A1 (en) A medicament for treatment of hypertension

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase